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ABSTRACT
The purpose of this research is to develop a method for assessing in vivo
protein-protein interactions in cultured cells that are permissive to Porcine
Reproductive and Respiratory Syndrome Virus (PRRSV) infection. The Non
Structural Protein 3 (NSp3) expressed by PRRSV was used as a prey to capture
interacting cellular proteins in protein cell lysates using a Pull-Down assay.
Interacting proteins were resolved by SDS-PAGE, extracted and identified by
means of mass spectrometry. Different alternatives have been tested to create
the optimal conditions for performing the technique that will allow further
confirmation of virus-host cells protein-protein interaction in PRRSV permissive
cells.
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REVIEW OF LITERATURE: PORCINE REPRODUCTIVE AND RESPIRATORY
SYNDROME VIRUS
Etiology:
The Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is an
enveloped, spherical, single-stranded positive-sense RNA virus 40-60 nm in diameter.
PRRSV is in the order of Nidovirales, family Arteriviridae, genus Arterivirus (Botner,
1994). There are two types of PRRSV viruses, one is the European isolate and the
other is the North American isolate. Sequence analysis showed that the virus isolates
are evolving by random mutation and intragenic recombination (Cho, 2006). Other
arteriviruses include equine arteritis virus (EAV), lactate dehydrogenase-elevating virus
(LDV), and simian hemorrhagic fever virus (SHFV). EAV, LDV and SHFV were isolated
and characterized in 1960s and 1970s; however, PRRSV was not isolated or
characterized until the 1990s (Snijder, 1998).
The polycistronic 3’-polyadenlated and 5’-capped arterivirus genome is 12-16 kb
long. The arterivirus genomes have a 5’ nontranslated region (NTR) of 156-224
nucleotides, and a 3’ NTR of 59-117 nucleotides. Arteriviruses contain 10-15 known
open reading frames (ORFs). Specifically, PRRSV contains eight ORFs (Xiang-Jin,
1995). Arteriviruses also contain two large ORFs named 1a and 1b, which take up
three-quarters of the genome at the 5’ proximal end (Snijder, 2013).
With very strict host cell specificity, LDV has been found to grow but not replicate
in primary cultures of mouse macrophages, and SHFV and PRRSV have been found to
replicate in primary macrophage cultures of simian and porcine origin as well as in
African green monkey kidney cells (MA-104) and their derivatives (CL2621 and MARC-
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145) (Snijder, 1998). Arteriviruses assemble by budding of nucleocapsids into the lumen
of the endoplasmic reticulum and/or Golgi apparatus, and are released from cells via
exocytosis. Although little is known about the replication cycle of arteriviruses, the
replication cycle begins with the expression of non-structural protein genes encoded by
ORF1a and ORF1b. Both arteriviruses and coronaviruses show discontinuous
subgenomic mRNA transcription of their genomes, which is one reason why they are
grouped together in the order of Nidovirales (Snijder, 1998).
Arteriviruses are spherical, enveloped virions with a diameter of 40-60 nm,
containing an isometric core particle of 25-35 nm in diameter. Furthermore, arteriviruses
contain a nucleocapsid protein, the N protein, with a molecular mass between 12-15
kDa, which represents 20-40% of the protein content of the virion. Immunoprecipitation
of N from purified PRRSV showed that the protein is present as disulfide-linked
homodimer. The non-glycosylated M protein of arteriviruses is the most conserved
structural protein, playing a role in the formation of disulfide bridges in receptor binding
(Snijder, 1998).
The severity of diseases resulting from arteriviruses varies on the specific virus
and strain as well as the condition and age of the animal infected. However, a variety of
symptoms from arteriviruses infections generally include respiratory distress,
hemorrhagic fever, and necrosis of small muscular arteries. Additionally, abortion in
pregnant animals, and a persistent presence of the virus in the semen of infected male
animals can be seen depending on the particular arterivirus (Snijder 1998).
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History of PRRSV
Porcine Reproductive and Respiratory Syndrome (PRRS), while the etiology was
unknown at the time, emerged in 1987 in the United States and Canada (Mystery
Disease); and, immediately impacted economics in the swine industry at a cost of
approximately $560 million US dollars per year in the 1990’s (Cho, 2006). By 1991,
PRRS had become widespread in Europe after similar clinical outbreaks were reported
in Germany in 1991. PRRSV as the viral agent for PRRS was identified by researchers
in The Netherlands and the United States, determining that there are two strains of
PRRSV: North American and European strains (Forsberg, 2002).
Clinical Aspects of PRRSV
Clinical signs of PRRSV in swine include severe reproductive failure, postweaning pneumonia, growth reduction, decreased performance, and increased
mortality. Specific reproductive failures include third-trimester abortions, premature
parturition, and higher levels of fetal losses. The degree of clinical PRRS varies
depending on the virulence of the PRRSV isolate as well as the animal age and
presence of bacterial co-infections (Cho, 2006).
Abortion rates from PRRSV infection vary greatly, and were reported as 3% in
The Netherlands, and over 80% in Spain. Other symptoms include periocular edema,
conjunctivitis, and eyelid edema, which were reported in Spain, Germany, and England.
In Europe and Canada, but not the United States, a blue discoloration of ears, teats,
snout, and ventral cervical skin, vulva, and abdomen was reported. Early signs of a
PRRSV infection include influenza-like symptoms such as conjunctivitis, depression,
lethargy, and anorexia lasting up to 2 weeks. Although death in older pigs in not
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common with a PRRSV infection, the virus can persist in infected herds and lead to
difficulty in breeding and growing pigs. In adult pigs, the signs tend to be milder and
consist of anorexia lasting 5-7 days, with an increased respiratory rate, listlessness, and
hyperexcitability. Additionally, adult pigs may show changes in body temperatures
ranging between 104°-106°F. Chronic pneumonia is also a complication of PRRSV and
contributes to an increase in mortality (Meulenberg, 2000).
Clinical manifestations are more severe in newborn and nursing pigs than in
adult pigs especially in the form of respiratory distress. A respiratory disorder called
“thumping” can occur with PRRSV infection in nursing pigs, which is caused by a virus
induced interstitial pneumonia. Newborn and nursing pigs also experience mouth
breathing, listlessness, lateral recumbency, paddling, sneezing, and vomiting. The
mortality rate of preweaning pigs could be up to 50-60% due to starvation or diarrhea.
The clinical signs in breeding pigs include late term abortions, stillbirths (5070%), and premature farrowing. Recovery can start up to 2-3 weeks after infection and
can result in a poor conception rate and a slower return to heat. Some herds have been
found to recover back to normal breeding routines after an outbreak, whereas other
herds show persistent effects including smaller litter sizes, and piglets born with a risk of
developing other diseases including atrophic rhinitis, enzootic pneumonia, and more
severe forms of Salmonella and other bacterial infections (Rossow, 1998)
Diagnosis of PRRSV
Diagnosis of PRRSV can be determined by clinical signs or laboratory based
testing including histopathology, serology, virus isolation and RT-PCR in clinical
samples obtained from sows and/or fetuses. However, diagnosis based on clinical signs
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alone is not ideal because of the great variety of clinical manifestations of PRRS from
pig to pig and from herd to herd. Additionally, secondary bacterial infections as well as
other diseases confound the clinical diagnosis of PRRS. Overall, if swine herds are
showing more than a 20% rate of stillbirths, late-term abortions, pre-mature farrowing
higher that 8%, or an increase in mortality rates of pigs within the first week of life
(>25%), then PRRS should be suspected. Histopathologically, a characteristic sign of
PRRSV infection of lungs includes the manifestation of interstitial pneumonia as
thickened alveolar septa with macrophages present (Figure 1). However, infection of
lungs with H1N1 and H3N2 strains of Influenza virus also result in thickened alveolar
septa with macrophage infiltration.

Figure 1. (a) Microscopic section of a normal pig lung. (b). Microscopic section of a lung from a
pig infected with PRRSV after 10 days. Necrotic debris and inflammatory cells are present in the
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alveolar spaces. (c). Microscopic section of a lung from a pig infected with PRRSV after 28
days. (d). Microscopic section of a lung from a pig infected with PRRSV after 28 days with both
M. hyopneumonia and PRRSV-induced pneumonia (Thacker, 1999).

Antibody detection in fetal fluids or pre-colostral blood of stillborn and newborns
as well as an increase in antibody titers in serum samples collected 3 weeks apart are
indicative of PRRSV infections. For PRRSV surveillance purposes, a minimum of 30%
of the herd should be serologically tested in order for a 95% confidence in the detection
of PRRSV infections. Virus isolation is ideal for samples collected from acutely infected
pigs presenting respiratory signs. PRRSV can be detected in lungs, spleen, lymph
nodes and serum. Infectious virus can also be obtained from the lung, spleen, heart,
blood, and thoracic fluids samples obtained from stillborn and aborted fetuses for up to
6-8 weeks after infection (Rossow, 1998).
PRRSV Transmission
Both infected pigs and contaminated semen contribute as direct routes for
PRRSV transmission. PRRSV has been found in blood, semen, saliva, feces, milk, and
colostrum of infected pigs. Vertical and horizontal transmissions of PRRSV have been
reported. Indirect routes of PRRSV transmission include fomites such as boots and
coveralls; transport vehicles; insects including mosquitoes and houseflies; avian and
non-porcine mammalian species and possibly waterfowl; and aerosols (Cho, 2006).
Aerosols are of high importance in the transmission of PRRSV, which is affected by
high humidity, low temperatures, and low wind speed (Rossow, 1998).
Although exact information on the incubation period of PRRS is unknown, a 37
day lag time has been reported between the virus entry and manifestation of signs of
the disease. Herds can remain infected for at least 2 months after signs of PRRS start

6

to fade away. The presence of the virus for a long period of time in infected herds is a
source for new infections (Rossow, 1998).
Treatment and control
Avoiding the introduction of PRRSV to a herd by means of quarantine is one
method of controlling PRRS. This also includes testing incoming pigs, restricting
visitors, changing boots and clothes after dealing with the pigs, and keeping stray
animals and rodents away. However, PRRSV can be transmitted as an aerosol, so
control through quarantine may not be entirely effective. Other means of control include
disposing of placentas, fetuses, and dead piglets immediately; cleaning farrowing areas
thoroughly after abortions or pre-mature farrowing; and disinfecting all entrances/exits of
breeding houses and transport vehicles (Rossow, 1998)
Vaccination against PRRSV also prevents the spread of disease in pigs.
Modified-live virus (MLV) commercial PRRSV vaccines have been available since 1994,
such as Ingelvac PRRS MLV (Boehringer Ingelheim Vetmedica, Inc) (Opriessnig, 2002).
Experiments have shown that vaccination with MLV vaccines in pigs reduces clinical
signs following a PRRSV challenge. Additionally, herd closure, sow acclimation, and
mass exposure can help to reduce the risk of PRRSV shedding and spreading (Cano,
2007).
PRRS virus
Mature viral particles produced from PRRSV infected cells are composed of an
envelope of 40-60 nm in diameter, surrounding a 20-30 nm isometric capsid that
includes an approximately 15 kb linear positive-stranded RNA genome. Mature virions
are released by exocytosis after being formed by the budding of preformed
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nucleocapsids into the lumen of the smooth endoplasmic reticulum and/or Golgi
apparatus (Dea, 2000).
PRRSV, as an enveloped virus, has a survivability outside the host that can be
affected by temperature, pH, and exposure to detergents. PRRSV can survive for over
four months at temperatures between -70 to -20°C, and remain stable at pH ranges
between 6.5 and 7.5. Detergents such as lipid solvents like chloroform and ether
effectively disrupt PRRSV’s viral envelope (Cho, 2006).
The PRRSV genome has nine open reading frames, which are transcribed in
cells as subgenomic mRNAs. ORF1a and ORF1b are at the 5’ end of the genome and
represent about 75% of the viral genome encoding non-structural proteins that are
involved in replication of the virus (Dea, 2000).
PRRSV has a restricted cell tropism in vivo and in vitro. The virus can infect welldifferentiated cells of the monocyte-macrophage lineage in vivo including particular
porcine alveolar macrophages (PAM). PRRSV also targets interstitial macrophages in
the heart, thymus, spleen, Peyer’s patches, hepatic sinusoids, renal medullary
interstitium and the adrenal gland. PRRSV RNA and nucleocapsid protein N were also
found by in situ hybridization (ISH) and immunohistochemistry in testicular germ cells,
endothelial cells in the heart, interdigitating cells in the thymus, dendritic cells in the
spleen and Peyer’s patches (Music, 2010).
PAM cells and blood-derived monocytes are the only porcine cells that can be
used to propagate PRRSV in vitro. However, MARC-145 and CL2621, which are
subclones of the MA104 monkey kidney line, are of non-porcine origin permissive cell
lines to PRRSV infection (Snijder, 1998).
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The virus enters cells via receptor-mediated endocytosis, this entry mechanism
was confirmed by Duan et al in 1998. In the same study, it was shown that PRRSV
interacts with heparin sulphate during binding to the cell surface, to sialoadhesins for
binding and internalization, and to vimentin. Higher expression of CD163, which is most
likely used for viral uncoating, also interacts with PRRSV on macrophages. PRRSV
infections induce apoptosis in cells in vivo as well as in vitro, which ultimately manifests
as DNA fragmentation and activation of caspases (Music, 2010).
PRRSV Protein Synthesis
The PRRSV genome encodes structural and non-structural (NS) proteins. The
major structural protein of PRRSV is encoded by ORF5, a 25 kDa envelope
glycoprotein known as GP5. The 18-19 kDa unglycosylated membrane protein M is
encoded by ORF6, and the 15 kDa nucleocapsid protein N is encoded by ORF7. The N
protein is highly antigenic, making it a prime target for detection of PRRSV infections
(Dea, 2000).
The life cycle of the virus begins with the expression of the large replicase gene
complex encoded by ORF1a and ORF1b, which translate polyproteins pp1a and pp1ab,
respectively (Figure 2). The pp1a polyprotein is cleaved at eight sites by viral and
cellular proteases, yielding nine non-structural proteins (NSps) including NSp1α,
NSp1β, and NSp2-NSp8. Cleavage of pp1ab polyprotein yields NSp9-NSp12. Although
little is known about the function of NSps of PRRSV, besides that together they show
replicase, protease, and polymerase functions, it is known that NSps generated from
the pp1a polyprotein express proteolytic activities; and that NSps generated from pp1ab
polyprotein are involved with transcription and replication functions (Music, 2010).
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Figure 2. Genome organization of PRRSV containing the 5’ proximal replicase ORFs 1a and 1b
with downstream ORFs that encode glycoproteins GP2
GP2-5, the envelope (E), membrane (M), and
nucleocsapsid (N) towards the 3’ end. Adapted from Fang, 2010.

Impact of the disease caused by PRRSV
Since the emergence of PRRSV in the 1980’s
1980’s-1990’s
1990’s in the United States, PRRS
has been recognized as a disease with major economic implications to the swine
industry (Albina, 1997). According to an economic assessment by the American
Association of Swine Veterinarians
terinarians in 2012, the total cost of productivity losses due to
PRRSV in the United States was estimated at $664 million yearly. This figure shows a
significant increase from the estimated $560 million annual cost in the 1990’s to 2005.
Therefore, PRRSV continues to be a critical virus to study as eradication efforts have
failed to lower the economic burden of the disease (Neumann, 1995).
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OBJECTIVE OF RESEARCH
The objective of this research is to develop a method to identify PRRSV-host
protein-protein interactions in cells that are permissive to the virus infection. The method
is based on a Pull-Down Assay that is designed to “capture” cellular proteins that bind to
PRRSV NSp3. Virus-host protein-protein interactions are vital to understanding
mechanisms underlying infection that result in manifestation of disease. Here, we are
studying the interactions of PRRSV NSp3, a viral protein involved in replication, with
cellular protein and its potential role in regulation of virus induced apoptosis. In addition,
establishing a Pull-Down technique to study protein-protein interactions in PRRSV in
general is of utmost importance for future research.
APPROACH
NSp3, a known protein expressed by PRRSV during infection, was used as a
“prey” protein in a Pull-Down Assay to “capture” interacting cellular proteins in cell
lysates obtained from PRRSV-permissive cells. The Pull-Down Assay protocol used
here (Pierce® GST Protein Interaction Pull-Down Kit) uses a Glutathione S-Transferase
(GST) based technique (Figure 3), where agarose gel beads bind to GST-tagged
proteins. The GST-tagged protein in this study was PRRSV NSp3 whereas GST protein
was used as control. GST-NSp3 was expressed in E.coli as a fusion protein and tested
for the ability to bind to glutathione coated beads. Cell lysates were prepared under
different conditions from MARC-145 cells that are permissive to PRRSV infection. After
testing the ability of GST-NSp3 to bind cellular proteins by incubating coated beads with
cellular lysates, beads were recovered and bound material separated by SDS-PAGE.
Identification of bound cellular proteins was performed by tryptic in-gel digestion of
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these proteins that interacted with the bait protein was conducted and identified by
means of mass spectrometry.

1.

2.

Agarose
glutathione
bead

Bait Protein
(NSp3)

Glutathione Affinity
Ligand (GST)

3.

Prey protein
identification by
Mass Spectrometry
Prey Protein
“captured” from mammalian cell
lysate

Figure 3. This schematic representation of a Pull-Down Assay describes the protocol in a
simplified three-step process. First, the agarose glutathione bead bound to a glutathione affinity
ligand (i.e.: GST) is prepared with the “bait” protein (i.e.: NSp3). Next, that “bait” protein, in this
case NSp3, is used to “fish” for “prey” proteins in a mammalian cell lysate, in this case from
PRRSV permissive MARC-145 cells. Finally, these “captured” “prey” proteins are eluted and
proteins identified by Mass Spectrometry. Adapted from Pierce® GST Protein Interaction PullDown Kit Instructions.
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PROCEDURES AND RESULTS
PRRSV NSp3 Synthesis using an E. coli Expression System: Cloning of GST-NSp3
fusion protein
The gene encoding for PRRSV NSp3 was amplified by means of the polymerase
chain reaction (PCR) using primers NSp3_pENTR_For 5’caccatgggaggcccgcacctc 3’
and NSp3_pENTR_Rev 5’gaattcttagtgatggtgatggtgatgctcaagaagggaccc 3’ targeting
plasmid pFL12 that contains a full-length DNA copy of PRRSV. The PCR conditions
were as follows: incubation at 95°C for 2 minutes, 35 cycles of 95°C for 30 s, 58°C for
30 s, and 68°C for 2 minutes, and final extension step of 68°C for 3 minutes. The
amplification was undertaken in a thermal cycler (Mastercycler, Eppendorf, Westbury,
NY). The resulting PCR fragment was eluted from a 1% agarose gel using the QIAEX II
Gel Extraction Kit (Qiagen, Valencia, CA), and directionally cloned into pENTR/DTOPO vector (Invitrogen, Carlsbad, CA) following instructions of the manufacturer. After
cloning, recovered plasmids were sequenced to assess fidelity of the cloned NSp3
gene. The NSp3 gene was transferred to vector pDEST15 (Invitrogen) that contains a 5’
end GST fusion tag, using homologous recombination. The reaction containing 7µL of
pENTR/D- TOPO-NSp3, 1µL of pDEST15, and 2µL of LR clonase was incubated for 1
hour at 25°C. After incubation, 1µL of proteinase K was added to the reaction that was
further incubated for 10 minutes at 37°C. The reaction mix was used to transform TOP10 chemically competent E. coli cells (Invitrogen) that were plated in Terrific Broth agar
plates in the presence carbenicillin for selection of bacteria containing pDEST15-NSp3.
Carbenicillin resistant bacteria were selected from the plates and grown overnight at
37°C in Terrific Broth-carbenicillin for isolation of plasmid DNA. After purification plasmid
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DNA was sequenced to assess the fidelity of GST-NSp3 fusion. pDEST15-NSp3 was
used for expressing the fusion protein.
Expression of GST-NSp3 fusion protein
BL21 (DE3) E. coli cells (Invitrogen) were transformed with plasmids pDEST15
and pDEST15-NSp3 harboring GST or GST-NSp3 fusion genes, respectively. Briefly;
2µL of Beta-mercaptoethanol (βME) were added to 100µL of BL21cells containing
microcentrifuge tubes labeled GST (control) or GST-NSp3. Cells were incubated on ice
for 10 minutes, and 1µL of pDEST15 or pDEST15-NSp3 was added to each tube
incubating on ice for 30 minutes. Next, BL21 cells were subject to a heat-shock at 42°C
for 45 seconds and placed back on ice for additional 2 minutes. Super Optimal Broth
medium (SOC), 250µL, was added to the transformed cells and incubated while shaking
for 1 hour at 37°C. Cells, 150µL were plated in Terrific Broth-agar plates containing 100
ug/ml of carbecillin, and incubated overnight at 37°C. Four colonies were selected from
the plates and grown for 21 hours at 37°C with shaking in MagicMedia (Invitrogen) to
induce expression and harvested by centrifugation at 3,200 x g for 15 min. The cell
pellets were treated with 1ml of CelLytic buffer (Sigma Aldrich, St. Louis, MO) in the
presence of 20µL of lysozyme and 5mL of 10x Tris Buffered Saline (TBS) according to
manufacturer’s large scale extraction protocol and saved at -200C. Cell lysates were
analyzed on a NuPAGE® Novex 12% Bis-Tris Gel (Invitrogen) by a discontinuous SDSPAGE system. MagicMark XP Protein Standard (Invitrogen) was used as a molecular
weight standard. For SDS-PAGE, 13µL of cell lysates were mixed with 5µL of NuPage
LDS Sample Buffer, 2µL of NuPage Reducing Agent, making a total volume of 20µL
Samples were heated at 70°C for 10 minutes and ran for 50 minutes at 200V, 100mA.

14

Gels were stained with Coomassie blue stain ((Colloidal Coomasie Blue).
). For Western
blots, separated proteins were transferred to p
polyvinylidene fluoride (PVDF) membrane
(Invitrogen). Briefly, blotting pads were soaked for 5 minutes in a transfer buffer
containing 12.5mL
mL of NuPAGE
NuPAGE® Transfer Buffer (Invitrogen), 250µL of antioxidant
(Invitrogen), 25mL
mL of methano
methanol and deionized water up to 250mL.
mL. PVDF membranes
were soaked in methanol for 30 seconds, rinsed with water 3 times, and soaked in
transfer buffer before transferring.
ansferring. The set up for the W
Western
estern blot consisted of 2 blotting
pads, filter paper,
per, gel, PVDF activated membrane, and two additional blotting pads
(Figure 4). The assembled unit was then placed in XCell II™ Blot module (Invitrogen)
and the transfer was completed by applying 30 volts for 1 hour.

Figure 4. Assembly of SDS-PAGE
PAGE gels for transferring of proteins to PVDF membranes using
the XCell II™ Blot module (Invitrogen).
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Western blots were developed using a Western Breeze Chemiluminescent
Detection Kit (Invitrogen) according with instructions provided by the manufacturer.
Briefly, after transfer, PVDF membranes were blocked for 4 hours at room-temperature,
with shaking, in blocking buffer containing 5mL of ultrapure water, 2mL of
Blocker/Diluent A, and 3mL of Blocker/Diluent B. After blocking, PVDF membranes
were rinsed 3 times with ultrapure water for 5 minutes each time and incubated
overnight with a mouse anti-GST antibody (Invitrogen) in a buffer containing 7mL of
ultrapure water, 2mL of Blocker/Diluent A, 1mL of Blocker/Diluent B and 4µL (1:2500
dilution) of the anti-GST antibody. After exposure to the primary antibody, the
membrane was washed 3 times for 5 minutes each wash with a washing buffer
containing 150mL of ultrapure water and 10mL of the Antibody Wash. After washes, the
membrane was then incubated in 10mL of anti-mouse secondary antibody solution for
30 minutes at room temperature, with shaking. After washing the excess of secondary
antibody as described above, protein bands were detected using CDP-star
chemiluminescent substrate provided with the kit and subsequently exposed to an X-ray
film (Kodak X-OMAT LS film, Kodak, Rochester, NY).
The results from the Western immunoblot are shown in Figure 5. Lanes 1 and 2
show the expression of GST-NSp3 fusion proteins and lanes 3 and 4 show the
expression of GST proteins.
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Figure 5. Detection of GST-NSp3
NSp3 and GST proteins expressed in E. col
coli.
i. Proteins were
detected in a Western
estern blot using Western Breeze Chemiluminescent Immunodetection
mmunodetection Kit
(Invitrogen).. Lanes 1 and 2: GST
GST-NSp3
NSp3 fusion protein; lanes 3 and 4: GST protein.
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Production of Glutathione-GST-NSp3 beads and detection of NSp3 binding proteins
After confirmation of expression of GST-NSp3 and GST proteins obtained with
the E.coli based expression system, these “bait proteins” were immobilized on the
surface of glutathione agarose beads. Here we used a Pierce™ GST Protein Interaction
Pull-Down Kit (Pierce-Thermo Fisher Scientific). Glutathione Agarose was used for
binding GST-fused NSp3 to the beads. Glutathione is linked by its central sulfhydryl to
agarose beads and using affinity chromatography, glutathione-agarose permits rapid
and highly selective binding and eventually purification of glutathione binding enzymes
such as glutathione S-transferase (GST). The overall scheme used for the production of
glutathione-GST-NSp3 beads and identification of NSp3 binding proteins is summarized
in the following figure.

Figure 6. Summary of the procedure used to detect and identify cellular proteins that bind to
NSp3. GST-NSp3 fusion was obtained from E. coli (step 1, bait preparation).
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Immobilization of GST-NSp3
A- Equilibrate Glutathione Agarose
Glutathione agarose resin were thoroughly resuspended by vortexing and 50µL of
the slurry was transferred to 1.5mL microcentrifuge tubes (Note: glutathione agarose is
supplied as a 50% slurry. Settled resin volume per assay is 25µL). Then, 400µL of the
wash solution buffer (1:1 solution containing TBS [25 mM Tris-HCL, 0.15 M NaCl, pH
7.2]-Pull-Down Lysis Buffer) were added to the tubes. Caps were closed and tubes
inverted several times to equilibrate the glutathione agarose resin. Tubes were then
spun at 1250 × g for 30 seconds to 1 minute. Wash solution was discarded. The
process was repeated for 5 times.
B- Immobilize Bait Protein
After equilibration, GST-NSp3 fusion proteins were added to the glutathione resin.
Five different binding conditions were tested as described in Table 1.
Combination

Volume of GST-NSp3 prep.
(µL)

Volume of TBS
(µL)

1

50

450

2

150

350

3

200

300

4

300

200

5

400

100

Table 1. Binding of GST-NSp3 and GST proteins to GST beads. Combination of proteins and
binding buffer tested.

GST-NSp3 and TBS were mixed and tubes were incubated at 4°C for at least 30
minutes with gentle rocking motion on a rotating platform (Note: Maximal binding may
require a longer incubation time, which should be determined for each new GST-tagged
fusion protein). After incubation, tubes were spun at 1250 × g for 30 seconds to 1
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minute. Supernatant was transferred to a fresh tube labeled “bait flow-through” and
placed on ice. After binding the resin was washed five times using 400µL of the wash
solution buffer followed by centrifugation 1250 × g for 30 seconds to 1 minute each time.
Western immunoblots were used to assess binding of GST-NSp3 and GST to the
glutathione beads using an anti-GST antibody. Briefly, beads were mixed with 6µL of
SDS-loading buffer and 1µL of reducing agent (Life Technologies), boiled for 10
minutes, and spun at 1250 × g for 30 seconds. Protein containing supernatants were
then resolved by Western blots following procedures explained above (Table 1).
Obtained data showed that lysate-TBS combination 4 (Table 2), containing 300µL of E.
coli derived lysate expressing GST-NSp3 protein, showed the highest binding as
determined by the highest intensity of GST-NSp3 signal relative to the signals observed
with the other combinations.
Lane

1

2

3

4

5

6

7

8

9

10

11

12

Sample

MW

PC

S-1

S-2

S-3

S-4

S-5

B-1

B-2

B-3

B-4

B-5

Table 2. After binding, supernants (S) and beads (B) from the 5 combinations described in table
1 were resolved by SDS-PAGE followed by a Western blot to detect GST-NSp3 proteins. The
highest band intensities were detected in lanes 6 and 11 that represent combination 4 of lysateTBS.

The immobilization of bait protein experiment was repeated again for the purpose of
testing additional combinations of E.coli lysate:TBS. Here, 200, 300, or 400µL of GST or
GST-NSp3 were mixed with TBS up to a total volume of 500µL followed by the steps
described above. Binding to glutathione beads was then assessed by Western
immunoblots as described above (Figure 4).
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Figure 7.. Detection of immobilized GST fusion proteins. X-ray
ray film from a Western blot using
anti-GST primary antibody (1:2500
1:2500). (A) Lanes 11 and 12 show the presence of GST protein at
~27 kDa, red arrow (B) lane show the presen
presence of GST at ~27 kDa and GST-NS
NSp3 at ~48 kDa,
red arrows.

These results show that the mixture containing 400µL of prot
protein
ein lysate (lanes 12 in
figure 7)) provided the highest binding to the glutathione beads.
Purification of the GST-NSp3
NSp3 proteins
In an attempt to improve binding of the fusion protein to the glutathione agarose,
GST-NSp3
NSp3 was purified by affinity chromatography using the Pierce® GST Spin
Purification Kit (Pierce-Thermo
Thermo Fisher Scientific) according to instructions provided by
the manufacturer.
facturer. Purification is based on the affinity of Glutathione
Glutathione-S-transferase
transferase
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(GST) for glutathione. Briefly, glutathione spin columns were centrifuged at 700 x g for
2 minutes in order to remove the storage buffer. Next, for equilibration, two resin-bed
volumes relative to resin of kit supplied Equilibration/Wash Buffer (containing Tris-HCL,
sodium chloride, pH8) was added to the columns, mixing by repeated inversions
followed by centrifugation at 700 x g for 2 minutes. GST-NSp3 lysate (1 mL) obtained
from E.coli was mixed in a 1:1 volume ratio with kit provided equilibration/ wash buffer.
For binding, the lysate:buffer mixture was then applied to a equilibrated glutathione
purification column followed by incubation at room temperature for 30 minutes with
shaking in an orbital shaker. For elution purposes, the column was centrifuged at 700 x
g for 2 minutes and flow through buffer collected in a centrifuge tube. The column was
then washed with two resin-bed volumes of Equilibration/Wash Buffer, centrifuging at
700 x g for 2 minutes and collecting fraction in a centrifuge tube. This washing step was
repeated two more times. GST-NSp3 protein was eluted from the resin by adding one
resin-bed volume of Elution Buffer (10X Glutathione stock solution provided with the kit
10-fold with Equilibration/Wash Buffer). Centrifuge at 700 × g for 2 minutes and
collecting the flow-through. This step was repeated two more times, collecting each
fraction in a separate tubes.
For assessing purity of GST-NSp3 collected fractions were resolved by SDSPAGE. Fractions (13µL) were combined with 5µL of SDS sample buffer, and 2µL of
reducing agent (Life Technologies). The gel was run at 200V for 50 minutes and
proteins transferred to PVDF membranes as described above. The presence of GSTNSp3 was determined by using an anti-GST antibody. No GST-NSp3 proteins were
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detected in the blots. Thus, our experiments continued using crude extracts from E.coli
expressing GST-NSp3.
Preparation of “prey” proteins from mammalian cells
The purpose of this experiment was to detect cellular proteins from mammalian
MARC-145 cells that bind to PRRSV NSp3.
First, two different lysis buffers were tested for preparing lysates of cultured
MARC-145 cells.
Cell monolayers containing approximately 107 cells were washed once with 5mL
of 1X PBS (phosphate buffered saline pH 7.2). Cells were then detached from the flask
using 2ml of 1X Trypsin-EDTA incubating at 370C (~ 2 minutes). Four milliliters of
complete tissue culture media (DMEM-10% fetal calf serum + antibiotics) were added to
the flask and the entire volume was transferred to a 15mL centrifuge tube. Cells were
centrifuged at 500 x g for 5 minutes, and supernatants discarded. Cell pellets were
washed by adding 5mL of 1X PBS followed by centrifugation at 500 x g for 5 minutes.
This step was repeated once.
After washing cells were resuspended in 3mL of RIPA buffer (Sigma-Aldrich) or
3mL of Cell Lytic B Buffer (Sigma-Aldrich) containing 20µL of lysozyme. Cells were then
incubated on ice for 30 minutes with shaking in an orbital shaker. After incubation, tubes
were centrifuged for 5 minutes at 12,000 x g to remove cellular debris. Supernatants
were transferred to clean tubes and stored at -200C until use. Aliquots of these lysates
were resolved by SDS-PAGE and gels stained with Simply Blue (Invitrogen) to visualize
cellular proteins. Higher protein yields were obtained when Cell Lytic B Buffer was used
to prepare the lysates.
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Capture of cellular proteins with Glutathione-GST-NSp3 beads
To capture cellular proteins with Glutathione-GST-NSp3 beads, a 1:1 volume
mixture containing 400µL of MARC-145 cell lysates: 400µL of TBS was added to the
beads. The mixture was then incubated in ice for 1 hour with shaking using an orbital
shaker. After incubation, mixtures were centrifuged for 1 minute at 1250 x g and the
supernatants saved as “prey flow-through GST” and “prey flow-through GST-nsp3”.
Next, 400µL of Wash Buffer was added to the tubes for washing the beads while gently
mixing by repeated inversions. Tubes were centrifuged at 1250 x g for 30 seconds and
supernatants were removed and discarded. This washing step was repeated 5 times.
After the last wash, the supernatant was discarded and agarose beads were
incubated at 700C for 10 minutes in the presence of 4µL of reducing agent (Life
Technologies) and 10µL of SDS sample buffer to elute bound proteins. Eluted proteins
were then resolved by SDS-PAGE followed by staining of the gels with Colloidal
Coomasie Blue.
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Figure 8. SDS PAGE Gel stained
ned with Colloidal Coomasie Blue showing cellular proteins that
interact with GST or GST-NSp3.
NSp3. Lanes: 1- Molecular weight marker; 2- MARC-145
145 cell lysate;
3- “bait” GST protein; 4- “bait: GST
GST-NSp3 protein; 5- flow-through GST; 6- flow-through
through GSTGST
NSp3; 7- empty lane; 8- wash 1 GST; 9
9- wash 2 GST-NSp3; 10- GST elute; 11-- GST-NSp3
elute; 12- BSA (bovine serum albumin).

Figure 9. Same as in figure 8 with increased contrast. Squares indicates the portion of the gel
that was excised for identification of cellular proteins using mass spectrometry (see below).
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Identification of cellular proteins that bind to PRRSV-NSp3
Elucidating the function of viral proteins involves determining the role of these
gene products during infection. In the cell, virus encoded proteins participate in an
extensive and intricate network of protein:protein interactions. The interaction of viral
proteins with cellular proteins most likely determines the fate of the infection. A
preliminary step, as it has been taken in this work, is to identify cellular proteins that
interact with PRRSV proteins, in this case PRRSV NSp3 protein. Here, we are
attempting to identify these interacting cellular proteins by means of Mass
Spectrometry. To accomplish that, “trapped” proteins by the glutathione-GST-NSp3
capture system that was established here, cellular proteins should be recovered and
then subject to identification.
Recovery of cellular proteins that interact with GST-NSp3
In-Gel Digestion using proteases
After resolving “trapped” cellular proteins by SDS-PAGE (as described above),
proteins were recovered from Colloidal Coomasie Blue (Life Technologies) stained gels
by in-gel tryptic digestion using the In-Gel Tryptic Digestion Kit (Pierce-Thermo Fisher
Scientific) according with instructions provided by the manufacturer.
Staining SDS-PAGE gels with Colloidal Coomasie Blue
To prepare SDS-PAGE gels for in-gel tryptic digestion, gels were stained using
Colloidal Blue Staining Kit (Life Technologies) for high sensitive staining of proteins.
After running, gels were washed 3 times for 5 minutes each time with ddH2O. Next, 10
mL of fixing solution (4mL of ddH2O, 5mL of methanol, and 1mL of acetic acid) was
added to the gels incubating for 10 minutes at room temperature with shaking. The
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fixing solution was then removed and a Staining Solution containing 5.5mL ddH2O, 2mL
of methanol, and 2mL of Stainer A Solution as provided with the kit, was added to gel
incubating for 10 minutes at room temperature with shaking. After the 10 minutes of
incubation, 0.5mL of Stainer B Solution was added to the gels that were further
incubated overnight (~12 hours) at room temperature with shaking. After overnight
incubation, the Staining Solution was removed and the gels were washed 3 times for 5
minutes each time with ddH2O. Images of stained gels were captured for analysis
purposes (Figures 8 and 9).
In-Gel Tryptic Digestion
Bands of interest observed in stained gels were recovered using an In-Gel
Tryptic Digestion Kit (Pierce-Thermo Fisher Scientific). To digest the bands selected in
the first pull-down experiment (Figure 9), stained gels were destained using a
Destaining Buffer containing 80mg of ammonium bicarbonate, 20mL of acetonitrile, and
20mL of ultrapure water. Using a sterile scalpel, ~1cm2 surrounding bands of interest in
lanes 10, 11, and 12 (Figure 9) were excised from the gel and placed into tubes labeled
GST, GST-NSp3, and BSA, respectively. Next, 200µL of the Destaining Buffer was
added to the tubes incubating at 37°C for 30 minutes with shaking. This step was
repeated once.
After destaining reduction and alkylation of recovered proteins were performed.
For reduction, 30µL of reducing buffer containing 3.3µL of TCEP
(Tris [2-carboxyethyl] phosphine) and 30µL of the Digestion Buffer (10mg of ammonium
bicarbonate in 5mL of ultrapure water) was added to the tubes incubating a 600C for 10
minutes. After cooling, the buffer was discarded. For alkylation, 30µL of 1X Alkylating
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Buffer (5X stock: 7mg of IAA [Iodoacetamide] in 70µL of ultrapure water) diluted in
Digestion Buffer (25 mM ammonium bicarbonate) was added to the samples that were
incubated in the dark at room temperature for 1 hour. Alkylation buffer was then
discarded and samples were washed by adding 200µL of Destaining Buffer followed by
incubation at 37°C for 15 minutes with shaking. The washing step was repeated once.
For digestion purposes, excised gel pieces were shrunk by adding 50µL of
acetonitrile incubating for 15 minutes at room temperature. Acetonitrile was discarded
and gel pieces were air-dried for 5 to 10 minutes. For swelling the gel pieces, 10µL of
Activated Trypsin solution (1µL of Trypsin Working Solution [5X trypsin stock diluted in
ultrapure water] in 9µL of Digestion Buffer) was added to the tubes that were incubated
for 15 minutes at room temperature. Then 25µL of Digestion Buffer was added to the
samples that were incubated at 30°C overnight with shaking. The digestion mixture,
containing peptides, was transferred to clean tubes. At this step samples were ready for
identification by means of Mass Spectrometry.
Mass Spectrometry of gel recovered proteins
Samples were submitted to the Laboratory of Mass Spectrometry and Omics
Analysis at the Department of Chemistry, University of Connecticut for protein
identification. Samples were processed by liquid chromatography-tandem mass
spectrometry (LC-MS/MS) with a QSTAR Elite LC/MS/MS System (AB Sciex) and
proteins were identified using Mascot software (Matrix Science). Mascot is a software
search engine that uses mass spectrometry data to identify proteins from peptide
sequence databases. By using this approach peptides were not detected or detected at
low levels in samples obtained from the pull-down experiment (Figure 9 lanes 10 and
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11), however bovine serum albumin was detected in the band excised from lane 12
(Figure 9) as expected. Most likely, the yield of cellular proteins obtained, as observed
in Figures 8 and 9, in the pull-down assays is low and not sufficient for detection by LCMS/MS. Although peptides that have no match with known proteins in the searched
database were identified in protein samples “trapped” with glutathione-GST-NSp3
capture setting (Table 3). Further experiments should be conducted to improve the yield
of NSp3 binding proteins.
Table 3. Peptide identified by LC-MS/MS data do not match to known proteins. Identified
peptides were detected in samples “trapped” with glutathione-GST-NSp3 capture setting.

Peptide

Sequence

1

IATDPAIR

2

RTEVTEGCLGLMRK

3

VLSNQVMTCEVVPISMTK

4

KFSSKLTDSK

5

YQMNVANGFR

6

AVRFSFTMSISIK

7

VVIKARGK
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DISCUSSION
The presence of GST-NSp3 observed by Western blots after expressing GSTNSp3 in the E. coli expression system confirmed that the transformation of BL21 cells
was successful, and that GST-NSp3 can be efficiently expressed. This protein was used
as “prey” to trap or capture cellular proteins in the pull-down assay developed here
(Figure 3). Using a mouse anti-GST antibody, the Western blot showed bands of the
expected molecular sizes. However, this GST-NSp3 proteins were only detected in
samples that were treated with the Cell Lytic B Buffer. One possibility of the lack of
GST-NSp3 could be from the Pull-Down Buffer’s properties not successfully working on
a bacterial system, as it is a mammalian cell buffer. The Cell Lytic B Buffer was the lysis
buffer of choice.
During the first round of GST-NSp3 and GST proteins binding and immobilization
to glutathione agarose beads, different volumes of E.coli obtained lysates were
combined with TBS and incubated with the glutathione beads to test for optimal binding
conditions (Table 1). It was observed that combining at least 300µL of protein lysate
with 200µL of TBS or less yielded the strongest signals in Western blots (Table 2 and
Figure 7). With the purpose of improving binding of GST and GST-NSp3 to the
glutathione beads, an attempt to purify proteins by affinity chromatography was made.
However, the amount of protein obtained by using the Pierce® GST Spin Purification Kit
was negligible. Further attempts should be made for improving purified protein yields.
As a results, crude E.coli cell lysates were used in this work.
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The pull-down assay using GST and GST-NSp3 and lysates from MARC-145
cells was successful although yielded low amounts of cellular proteins as observed in
figures 8 and 9. Nonetheless, proteins were purified using an in-gel tryptic digestion and
obtained peptides were submitted for Mass Spectrometry Analysis. Although the
amount of peptides obtained in this pull-down was low and not readily detected by the
LC-MS/MS analysis, BSA that was used as control was detected. Also, peptides with
not matches in the protein database were detected in samples from the GST-NSp3 pulldown.
Overall, the data presented here suggest that the entire process established
including cloning, expression, binding, pull-down, in-gel digestion and LC-MS/MS
worked successfully and will require further adjustments.
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